全文获取类型
收费全文 | 1798篇 |
免费 | 114篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 82篇 |
妇产科学 | 15篇 |
基础医学 | 173篇 |
口腔科学 | 60篇 |
临床医学 | 152篇 |
内科学 | 412篇 |
皮肤病学 | 25篇 |
神经病学 | 57篇 |
特种医学 | 252篇 |
外科学 | 209篇 |
综合类 | 77篇 |
一般理论 | 1篇 |
预防医学 | 217篇 |
眼科学 | 23篇 |
药学 | 69篇 |
中国医学 | 9篇 |
肿瘤学 | 75篇 |
出版年
2022年 | 4篇 |
2021年 | 16篇 |
2020年 | 11篇 |
2019年 | 16篇 |
2018年 | 18篇 |
2017年 | 17篇 |
2016年 | 11篇 |
2015年 | 28篇 |
2014年 | 50篇 |
2013年 | 86篇 |
2012年 | 54篇 |
2011年 | 66篇 |
2010年 | 45篇 |
2009年 | 73篇 |
2008年 | 68篇 |
2007年 | 89篇 |
2006年 | 54篇 |
2005年 | 67篇 |
2004年 | 54篇 |
2003年 | 49篇 |
2002年 | 53篇 |
2001年 | 40篇 |
2000年 | 52篇 |
1999年 | 49篇 |
1998年 | 92篇 |
1997年 | 70篇 |
1996年 | 73篇 |
1995年 | 56篇 |
1994年 | 59篇 |
1993年 | 49篇 |
1992年 | 24篇 |
1991年 | 23篇 |
1990年 | 28篇 |
1989年 | 54篇 |
1988年 | 40篇 |
1987年 | 37篇 |
1986年 | 28篇 |
1985年 | 18篇 |
1984年 | 19篇 |
1983年 | 21篇 |
1982年 | 15篇 |
1981年 | 22篇 |
1980年 | 13篇 |
1979年 | 11篇 |
1978年 | 14篇 |
1977年 | 22篇 |
1976年 | 14篇 |
1975年 | 16篇 |
1974年 | 4篇 |
1972年 | 7篇 |
排序方式: 共有1921条查询结果,搜索用时 31 毫秒
71.
72.
Villenave R Thavagnanam S Sarlang S Parker J Douglas I Skibinski G Heaney LG McKaigue JP Coyle PV Shields MD Power UF 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(13):5040-5045
Respiratory syncytial virus (RSV) is the major viral cause of severe pulmonary disease in young infants worldwide. However, the mechanisms by which RSV causes disease in humans remain poorly understood. To help bridge this gap, we developed an ex vivo/in vitro model of RSV infection based on well-differentiated primary pediatric bronchial epithelial cells (WD-PBECs), the primary targets of RSV infection in vivo. Our RSV/WD-PBEC model demonstrated remarkable similarities to hallmarks of RSV infection in infant lungs. These hallmarks included restriction of infection to noncontiguous or small clumps of apical ciliated and occasional nonciliated epithelial cells, apoptosis and sloughing of apical epithelial cells, occasional syncytium formation, goblet cell hyperplasia/metaplasia, and mucus hypersecretion. RSV was shed exclusively from the apical surface at titers consistent with those in airway aspirates from hospitalized infants. Furthermore, secretion of proinflammatory chemokines such as CXCL10, CCL5, IL-6, and CXCL8 reflected those chemokines present in airway aspirates. Interestingly, a recent RSV clinical isolate induced more cytopathogenesis than the prototypic A2 strain. Our findings indicate that this RSV/WD-PBEC model provides an authentic surrogate for RSV infection of airway epithelium in vivo. As such, this model may provide insights into RSV pathogenesis in humans that ultimately lead to successful RSV vaccines or therapeutics. 相似文献
73.
74.
目的探讨金属对金属(金对金)大头径假体微创全髋关节置换术(THA)治疗青中年股骨头坏死Ⅲ、Ⅳ期的临床疗效。方法本组32例(35髋)青中年股骨头缺血性坏死Ⅲ、Ⅳ期患者,年龄24~59岁,平均45岁,术前髋关节Harris评分平均(37.9±7.5)分;以改良后外侧小切口、肌间隙人路、充分保留关节动力性组织结构为特征的金对金大头径微创THA治疗。术中严格采取正确的假体植入技术,术中保留完整的软骨下骨和髋臼横韧带,击入臼杯时一次性安装成功,正确运用万古霉素预防感染。术后口服利伐沙班片抗凝,术后12h开放负压引流及卧床行功能锻炼,术后第2天拔除引流管后扶拐下地部分负重行走,术后2—3周患者即可弃拐完全负重行走。结果本组32例35髋患者均获随访,随访时间为12个月~6年,平均为4年。所有患者切口均一期愈合,无深静脉血栓形成、关节脱位、坐骨神经损伤、髋臼及股骨疲劳骨折、关节疼痛等严重并发症,X线片示髋关节假体位置均良好,无松动、移位、股骨柄下沉、假体周围骨折等表现。末次随访Harris评分由术前平均(37.9±7.5)分,提高至术后平均(92.2±4.6)分,前后比较有统计学意义(t=44.341,P〈0.05)。所有患者末次随访时髋关节功能明显优于术前,均对治疗效果满意,完全恢复正常生活及工作。结论采用金对金大头径微创THA治疗青中年股骨头坏死Ⅲ、Ⅳ期患者,能够明显降低手术风险,缩短卧床时问,迅速恢复髋关节功能,减少手术并发症,取得了满意的近期临床疗效。随着基础和临床研究的不断深入,金对金大头径髋关节假体的长期疗效还需要进一步探讨。 相似文献
75.
目的提高对巨大前列腺囊腺瘤的认识。方法回顾性分析收治的1例巨大前列腺囊腺瘤并成功进行腹腔镜切除的临床资料,结合文献复习进行讨论。结果本例患者成功行腹腔镜完整切除,手术时间125min,出血量60ml,术中双侧精囊输精管完整保留,术后会阴部坠胀不适消失,复查精液常规精子数目及活动度正常。已随诊12个月,肿瘤无复发。结论巨大前列腺囊腺瘤罕见,最终确诊要依靠病理诊断,其最有效的治疗是手术完整切除,而腹腔镜途径可作为完整切除的微创手段。 相似文献
76.
Amanda K Arrington Rebecca A Nelson Ann Falor Carrie Luu Rebecca L Wiatrek Marwan Fakih Gagandeep Singh Joseph Kim 《World journal of gastrointestinal surgery》2013,5(6):178-186
AIM:To examine surgical and medical outcomes for patients with cholangiocarcinoma using a populationbased cancer registry.METHODS:Using the California Cancer Registry’s Cancer Surveillance Program,patients with intrahepatic cholangiocarcinoma treated in Los Angeles County from 1988 to 2006 were identified and evaluated for clinical and pathologic factors and therapies received(surgery,radiation,and chemotherapy).The surgical cohort was further categorized into three treatment groups:patients who received adjuvant chemotherapy,adjuvant chemoradiation,or underwent surgery alone(no chemotherapy or radiation administered).Survival was assessed by Kaplan-Meier method;and Cox proportional hazard modeling was used in multivariate analysis.RESULTS:Of 825 patients,60.2% received no treatment.Of the remaining 328 patients,18.5% chemotherapy only,7.4% chemoradiation,and 13.8% underwent surgery.More male patients underwent surgical resection(P = 0.004).Surgical patients were younger than the patients receiving chemotherapy or chemoradiation(P < 0.001).Of the surgical cohort(n = 114),60.5% underwent surgery alone while 39.5% underwent surgery plus adjuvant therapy(chemotherapy n = 20;chemoradiation,n = 21)(P < 0.001).Median survival for all patients in the study was 6.6 mo.Median survival was highest for patients who underwent surgery(23 mo),whereas both chemotherapy(9 mo) and chemoradiation(8 mo) alone were each less effective(P < 0.001).By multivariate analysis,extent of disease,receipt of surgery,and administration of chemotherapy(with/without surgery) were independent predictors of overall survival.CONCLUSION:This study demonstrates that surgery is a critical treatment modality.Multimodality treatment has yet to be standardized,but play a role in optimal therapy for cholangiocarcinoma. 相似文献
77.
Lindsay N. Avolio Tyler J. S. Smith Ana Navas-Acien Kate Kruczynski Nora Pisanic Pranay R. Randad Barbara Detrick Rebecca C. Fry Alexander van Geen Walter Goessler Ruth A. Karron Sabra L. Klein Elizabeth L. Ogburn Marsha Wills-Karp Kelsey Alland Kaniz Ayesha Brian Dyer Md. Tanvir Islam Habibat A. Oguntade Md. Hafizur Rahman Hasmot Ali Rezwanul Haque Saijuddin Shaikh Kerry J. Schulze A. K. M. Muraduzzaman A. S. M. Alamgir Meerjady S. Flora Keith P. West Jr. Alain B. Labrique Christopher D. Heaney for the JiVitA Maternal Child Health Nutrition Research Project 《Paediatric and perinatal epidemiology》2023,37(2):165-178
Background
Arsenic exposure and micronutrient deficiencies may alter immune reactivity to influenza vaccination in pregnant women, transplacental transfer of maternal antibodies to the foetus, and maternal and infant acute morbidity.Objectives
The Pregnancy, Arsenic, and Immune Response (PAIR) Study was designed to assess whether arsenic exposure and micronutrient deficiencies alter maternal and newborn immunity and acute morbidity following maternal seasonal influenza vaccination during pregnancy.Population
The PAIR Study recruited pregnant women across a large rural study area in Gaibandha District, northern Bangladesh, 2018–2019.Design
Prospective, longitudinal pregnancy and birth cohort.Methods
We conducted home visits to enrol pregnant women in the late first or early second trimester (11–17 weeks of gestational age). Women received a quadrivalent seasonal inactivated influenza vaccine at enrolment. Follow-up included up to 13 visits between enrolment and 3 months postpartum. Arsenic was measured in drinking water and maternal urine. Micronutrient deficiencies were assessed using plasma biomarkers. Vaccine-specific antibody titres were measured in maternal and infant serum. Weekly telephone surveillance ascertained acute morbidity symptoms in women and infants.Preliminary Results
We enrolled 784 pregnant women between October 2018 and March 2019. Of 784 women who enrolled, 736 (93.9%) delivered live births and 551 (70.3%) completed follow-up visits to 3 months postpartum. Arsenic was detected (≥0.02 μg/L) in 99.7% of water specimens collected from participants at enrolment. The medians (interquartile ranges) of water and urinary arsenic at enrolment were 5.1 (0.5, 25.1) μg/L and 33.1 (19.6, 56.5) μg/L, respectively. Water and urinary arsenic were strongly correlated (Spearman's ⍴ = 0.72) among women with water arsenic ≥ median but weakly correlated (⍴ = 0.17) among women with water arsenic < median.Conclusions
The PAIR Study is well positioned to examine the effects of low-moderate arsenic exposure and micronutrient deficiencies on immune outcomes in women and infants. Registration : NCT03930017. 相似文献78.
79.
八项肝纤维化血清标志物比较研究 总被引:36,自引:0,他引:36
目的比较血清血小板衍生生长因子-BB(PDGF-BB)、转化生长因子-β1(TGF-B1)、基质金属蛋白酶抑制剂-1(TIMP-1)、基质金属蛋白酶-1(MMP-1)、透明质酸(HA)、Ⅲ型前胶原(PC Ⅲ)、Ⅳ型胶原(C Ⅳ)和层黏连蛋白(LN)及外周血单个核细胞(PBMC)内TIMP-1 mRNA、MMP-1 mRNA在肝纤维化中的诊断价值。方法常规肝穿活检、组织病理学诊断;RT-PCR检测PBMCs中MMP-1 mRNA、TIMP-1 mRNA水平;酶标法检测血清PDGF-BB、TGF-β1、TIMP-1和MMP-1含量;放射免疫法检测血清HA、PC Ⅲ、C-Ⅳ和LN含量。结果经ROC曲线分析,血清PDGF-BB、TIMP-1、HA、PC Ⅲ、C-Ⅳ、LN和TIMP-1 mRNA的AUC分别为0.985、0.726、0.318、0.728、0.727、0.583、0.463、0.876;血清PDGF-BB和PBMCs中TIMP-1 mRNA的灵敏度和特异度分别为90%、95%,73.7%、100%;两者联合检测的灵敏度为97.4%,特异度为95.0%。结论八项指标中,血清PDGF-BB的诊断价值最大。在筛选肝纤维化患者时,以血清PDGF-BB、PBMC中TIMP-1 mRNA联合检测最佳。 相似文献
80.
In order to determine the prognostic significance of thrombocytosis in idiopathic sideroblastic anemia, the clinical courses of 17 patients were reviewed. Six patients (36%) had thrombocytosis, and none developed acute leukemia. Nine patients (53%) had normal platelet counts, and one developed acute leukemia. Two patients (12%) were thrombocytopenic, and one died of acute leukemia. There was little correlation between survival and platelet count. Sixty-three additional case reports of idiopathic sideroblastic anemia were collected from the literature. Analysis of those patients and the patients in the present study documented transformation to acute leukemia in 5 of 9 (56%) thrombocytopenic patients, 4 of 54 (7.4%) patients with normal platelet counts, and 0 of 17 patients with thrombocytosis (p less than 0.05). Therefore patients with idiopathic sideroblastic anemia and thrombocytosis appear to have a decreased likelihood of leukemic transformation. 相似文献